Page 12 - GlaxoSmithKline Pharmaceuticals AR 2012

8
them to redesign their business models. All these posed risk in supply continuity coupled
with increasing cost. However, a combination of strategic commodity management and
integration with global and regional management structure helped your Company in
mitigating these price and security of supply pressures to a great extent. Another focus
area was to launch “Green Sourcing” and reduction of carbon footprint of your Company’s
supply chain. A benchmark exercise of carbon emission from your Company’s key vendors
was initiated.
Manufacturing
The India manufacturing operations have a roadmap and long term strategy aligned with the
global strategy. Capacity expansion projects of Ampoules and Eltroxin have been started at
the Nashik site this year. Your Company also continues to work on building capacities through
dual sourcing for key products. The Nashik site is continuously building capabilities through
productivity, OEE improvements, recruitment of professionals, specifically in Quality, EHS and
Manufacturing, as well as recruitment of fresh diploma engineers on the shop floor. Over a
period, the site has developed capabilities of supplying to Government Tenders which are in
generic drug form and highly customised packs.
Manufacturing Excellence
In line with Global Manufacturing and Supply initiatives, your Company has been working
on strategy deployment, performance management, lean leadership, visual factory,
gemba with purpose etc. Through strategy deployment the Nashik site is striving to engage
everybody and aligning the collective efforts of everyone with the site roadmap to deliver
the business goals. Several improvement projects have been identified related to OEE
improvement, cost reduction, productivity improvement, quality and safety improvement
which are in progress.
Lean sigma training was imparted to 26 supervisors from different functions. They are working
on the improvement projects in their respective areas. A benchmarking study –Pharma
Operations Benchmarking of Solids (POBOS) was done for solid dose value stream to assess
where your Company stands as compared to other sites within GlaxoSmithKline Group. In
most of the areas your Company is in the top position. An action plan has been drawn up by
the site to further strengthen manufacturing and Quality infrastructure.
Logistics
Keeping in mind the growing business and complexities, actions were taken to re-align
processes and infrastructure during the year. In tune with your Company’s commitment
to Quality and Compliance, major projects got started in consolidation of warehouses,
augmenting warehousing capability in terms of space, temperature controlled storage area
and fulfilling other basic needs. While supply position was challenged for a few brands, overall
positive trend in supply performance especially in vaccines helped supporting the larger
business performance.
(h) Corporate Social Responsibility
As a part of its social development initiatives, your Company continued its dedicated efforts
towards social programmes by continued support to ongoing long term projects and
commissioning many new activities.
Gramin Arogya Vikas Sanstha (GAVS), a registered public trust, promoted by the Company,
gave new shape to its Tribal health care project with its partner NGO, Niramaya Health
Foundation. The Project is now covering 60 villages through nine health centres and
mobile van clinics in Nashik, Maharashtra. In 2012, this project has impacted the lives of
30,000 direct beneficiaries and 1.25 lakh indirect beneficiaries through health checkups and
education sessions.
GAVS in partnership with Kherwadi Social Welfare Association (KSWA) has worked towards
“enhancing employment through Vocational and Skill Development Training” among
underprivileged rural tribal youth in Nashik. This year, the project covered 1000 youths for
training. Your Company continued its support to Institute for Indian Mother and Child (IIMC), a
non-government organization. The major objectives of the project includes providing primary
health care services to mother and child, work and educate community on services related to
antenatal care, natal and post natal care. During the year more than 1.2 lakh mothers have
been covered for maternal and child health.